The direct link between development and pharmaceutical production is a key factor in InnoMedica's innovative strength. Initially, setting up an in-house production facility involved a considerable risk due to higher investment costs and slower project progress. However, as is now becoming apparent, this strategy has clear advantages in the long term.

With the company's own nanofactory in Marly near Fribourg, findings from development can be tested promptly and flexibly in technologically optimized manufacturing processes, and knowledge gained in this process can in turn be fed back into development. InnoMedica has been able to position itself very well in international competition thanks to the knowledge gained in manufacturing as well as in pharmacy and nanobiochemistry, and therefore has a broad pipeline of new products and international patents in nanotechnology and its application.


Platform Patents


Specific Product Patents

Other Topics


InnoMedica's main focus in drug development is on efficient drug logistics in the human body.


Thanks to the multi-purpose design of InnoMedica's cleanrooms, they can be flexibly used for the production of different drugs in a modular way.